| |
|
Leadership - Board of Directors
- Christopher Mirabelli, Ph.D., Chairman
Managing Director, HealthCare Ventures
- Mark J. Enyedy
Chief Executive Officer, Proteostasis Therapeutics, Inc.
- Jeffery W. Kelly, Ph.D.
Lita Annenberg Hazen Professor of Chemistry, Chairman,
Molecular and Experimental Medicine, The Scripps Research Institute
- Stephen Knight, M.D.
Managing Partner, Fidelity Biosciences
- G. Kelly Martin
Chief Executive Officer, Elan Corporation
- Peter H. Reinhart, Ph.D.
President and Chief Scientific Officer, Proteostasis Therapeutics, Inc.
- Lauren Silverman, Ph.D.
Managing Director, Novartis Option Fund
- Christopher T. Walsh, Ph.D.
Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology,
Harvard Medical School
- Alan Walts, Ph.D.
Managing Director, Genzyme Ventures
|
|
